Unidad de Hematologia y Oncologia de Santander S.A.S. is based in Colombia. The head office is in Bucaramanga. The company operates in the Ambulatory Health Care Services sector. Unidad de Hematologia y Oncologia de Santander S.A.S. was incorporated on August 04, 2010. There are currently 18 (2025) people employed by Unidad de Hematologia y Oncologia de Santander S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 2.7% in 2024. Its’ total assets recorded a negative growth of 0.73%.

Headquarters
Cra. 36 # 48-98
Bucaramanga; Santander;

Contact Details: Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.

Website: http://www.unidhos.com.co

Basic Information

Total Employees:

Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.

Registered Capital:

Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.

Financial Auditors:

Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.

Incorporation Date:

August 04, 2010

Key Executives

Purchase this report to view the information.

Legal Representative

Company Performance

Financial values in the chart are available after Unidad de Hematologia y Oncologia de Santander S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.

Net sales revenue

2.7%▲

Total operating revenue

2.7%▲

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total Assets

-0.73%▼

Total Equity

56.76%▲

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt/Equity

-70.93%▼

Quick Ratio

-0.17%▼

Cash Ratio

Unidad de Hematologia y Oncologia de Santander S.A.S. (Colombia)